Repligen Corporation (RGEN) Narrowly Beats Estimates, Posts Q2 3c Loss
Repligen Corporation (NASDAQ: RGEN) reports Q2 loss of $0.03, 1 cent better than the analyst estimate of ($0.04). Revenue for the quarter was $5.42 million, which compares to the estimate of $5.19 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Patterson Companies, Inc. (PDCO) Tops Q4 EPS by 5c; Guides FY12
- Talbots, Inc. (TLB) Posts Surprise Q1 Profit; Comps Dip 3.8%
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
